ID: ALA2323434

Max Phase: Preclinical

Molecular Formula: C16H28Cl2N4

Molecular Weight: 276.43

Molecule Type: Small molecule

Representations

Canonical SMILES:  C[n+]1ccn(CCCCCCCCn2cc[n+](C)c2)c1.[Cl-].[Cl-]

Standard InChI:  InChI=1S/C16H28N4.2ClH/c1-17-11-13-19(15-17)9-7-5-3-4-6-8-10-20-14-12-18(2)16-20;;/h11-16H,3-10H2,1-2H3;2*1H/q+2;;/p-2

Standard InChI Key:  OLSDEZQOJHMNLQ-UHFFFAOYSA-L

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 276.43

Molecular Weight (Monoisotopic): 276.2303

AlogP: 1.98

#Rotatable Bonds: 9

Polar Surface Area: 17.62

Molecular Species: NEUTRAL

HBA: 2

HBD: 0

#RO5 Violations: 0

HBA (Lipinski): 4

HBD (Lipinski): 0

#RO5 Violations (Lipinski): 0

CX Acidic pKa:

CX Basic pKa:

CX LogP: -4.76

CX LogD: -4.76

Aromatic Rings: 2

Heavy Atoms: 20

QED Weighted: 0.49

Np Likeness Score: -0.18

References

1. Gao Y, Vlahakis JZ, Szarek WA, Brockhausen I..  (2013)  Selective inhibition of glycosyltransferases by bivalent imidazolium salts.,  21  (5): [PMID:23375091] [10.1016/j.bmc.2012.12.034]

2. Kocev A, Melamed J, Wang S, Kong X, Vlahakis JZ, Xu Y, Szarek WA, Brockhausen I..  (2020)  Inhibition of bacterial growth and galactosyltransferase activity of WbwC by α, ω-bis(3-alkyl-1H-imidazolium)alkane salts: Effect of varying carbon content.,  28  (11): [PMID:32312486] [10.1016/j.bmc.2020.115494]

Source

Source(1):

• Scientific Literature